SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S Zhong, W Chen, X Yu, Z Chen, Q Hu, J Zhao, Coffee consumption and risk of prostate cancer: an up-to-date meta-analysis, European Journal of Clinical Nutrition, 2014, 68, 3, 330

    CrossRef

  2. 2
    Yousra Souiden, Manel Mahdouani, Kamel Chaieb, Rafik Elkamel, Kacem Mahdouani, CYP17 gene polymorphism and prostate cancer susceptibility in a Tunisian population, Cancer Epidemiology, 2011, 35, 5, 480

    CrossRef

  3. 3
    Jason L Nelles, Wen-Yang Hu, Gail S Prins, Estrogen action and prostate cancer, Expert Review of Endocrinology & Metabolism, 2011, 6, 3, 437

    CrossRef

  4. 4
    Andrea Salonia, Andrea Gallina, Alberto Briganti, Firas Abdollah, Nazareno Suardi, Umberto Capitanio, Renzo Colombo, Massimo Freschi, Patrizio Rigatti, Francesco Montorsi, Preoperative hypogonadism is not an independent predictor of high-risk disease in patients undergoing radical prostatectomy, Cancer, 2011, 117, 17
  5. 5
    Cosimo De Nunzio, Alfonso Carluccini, Antonio Cicione, Stefano Squillacciotti, Alberto Trucchi, Andrea Cantiani, Costantino Leonardo, Andrea Tubaro, Prostate Cancer Does Not Influence Androgen Levels: A Radical Prostatectomy Cohort Study, Urologia Internationalis, 2011, 86, 2, 161

    CrossRef

  6. 6
    Matthew T. Johnson, Gregory J. Lowe, Robert R. Bahnson, Androgen deprivation therapy: a primer on concepts and therapeutic options, Journal of Men's Health, 2010, 7, 4, 358

    CrossRef

  7. 7
    Jean Fiet, Frank Giton, Circulating steroid hormones in prostate carcinogenesis. Part 1 – Androgens, Hormone Molecular Biology and Clinical Investigation, 2010, 3, 1

    CrossRef

  8. You have full text access to this Open Access content8
    Norie Sawada, Motoki Iwasaki, Manami Inoue, Shizuka Sasazuki, Taiki Yamaji, Taichi Shimazu, Shoichiro Tsugane, Plasma testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer among Japanese men: A nested case-control study, Cancer Science, 2010, 101, 12
  9. 9
    Ernani Luis Rhoden, Márcio Augusto Averbeck, Testosterone therapy and prostate carcinoma, Current Urology Reports, 2009, 10, 6, 453

    CrossRef

  10. 10
    Paras B. Singh, Shyam S. Matanhelia, Francis L. Martin, A potential paradox in prostate adenocarcinoma progression: Oestrogen as the initiating driver, European Journal of Cancer, 2008, 44, 7, 928

    CrossRef

  11. 11
    Ernani Luis Rhoden, Márcio Augusto Averbeck, Patrick E. Teloken, Androgen Replacement in Men Undergoing Treatment for Prostate Cancer, The Journal of Sexual Medicine, 2008, 5, 9
  12. 12
    Sara Wirén, Pär Stattin, Androgens and prostate cancer risk, Best Practice & Research Clinical Endocrinology & Metabolism, 2008, 22, 4, 601

    CrossRef

  13. 13
    Jocelyn M. Weiss, Wen-Yi Huang, Sabina Rinaldi, Thomas R. Fears, Nilanjan Chatterjee, Ann W. Hsing, E. David Crawford, Gerald L. Andriole, Rudolf Kaaks, Richard B. Hayes, Endogenous sex hormones and the risk of prostate cancer: A prospective study, International Journal of Cancer, 2008, 122, 10
  14. 14
    Giuseppe Carruba, Estrogen and prostate cancer: An eclipsed truth in an androgen-dominated scenario, Journal of Cellular Biochemistry, 2007, 102, 4
  15. 15
    Allen D. Seftel, Martin M. Miner, Robert A. Kloner, Stanley E. Althof, Office Evaluation of Male Sexual Dysfunction, Urologic Clinics of North America, 2007, 34, 4, 463

    CrossRef